LSE Equity Snapshot
HEMO Weekly Equity Report
Hemogenyx Pharmaceuticals Plc
What the company does
Hemogenyx Pharmaceuticals Plc, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of treatments for blood cancer. The company's lead product candidate is the HG-CT-1 therapy for the treatment of relapsed or refractory acute myeloid leukemia. It also develops chimeric bait receptor to treat viral infections derived and for certain cancer and neurological conditions; and CDX bi-specific antibody which eliminates hematopoietic stem cells/hematopoietic progenitors in a patient using bi-specific antibodies; and therapies for the improvement of bone marrow and blood stem cell transplant procedures. Hemogenyx Pharmaceuticals Plc was incorporated in 2013 and is …
What the weekly tape is saying
HEMO closed the latest completed week at 825.5 GBP. The 4-week return is 21.5% and the 12-week return is -9.9%. Trend Signal is inactive, Market Dynamics is -0.91. Setup signature: Balanced read with a 48/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 788.4 GBP
- Vs Trend Line
- 4.7%
- Fair Value
- 637.1 GBP
- Vs Fair Value
- 29.6%
- 52W High
- 1,800 GBP
- 52W Low
- 124.0 GBP
- Drawdown
- -54.1%
- Range Position
- 41.9%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 25
- 52W Active Breadth
- 48.1%
- Sector Scope
- GB Healthcare
- Sector Rank
- 3 of 78
- Sector Percentile
- 97.4%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
GB Healthcare
- Tracked Peers
- 78
- 4W Rank
- 7 of 78
- Avg 1W
- -2.0%
- Avg 4W
- -0.2%
- Trend Breadth
- 38.5%
- Positive MD
- 55.1%
GB Biotechnology
- Tracked Peers
- 29
- 4W Rank
- 4 of 29
- Avg 1W
- -3.7%
- Avg 4W
- -0.5%
- Trend Breadth
- 37.9%
- Positive RS
- 34.5%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.91
- 4W MD Change
- -18.2%
- Relative Strength
- 10.20
- 4W RS Change
- 774.6%
- Expectation
- Negative
- Probability
- 43.63%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 96.3K
- 13W Average
- 110.2K
- 52W Average
- 276.3K
- Vs 13W
- 0.9x
- Vs 52W
- 0.3x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 8.9%
- 52W Volatility
- 32.8%
- Upside Weeks
- 26
- Downside Weeks
- 25
- Downside Breadth
- 48.1%
- Avg Gain / Loss
- 21.9% / -10.2%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- LSE
- Country
- GB
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- GBP
- Market Cap
- 47.5M
Opportunity signals
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Latest weekly return ranks in the strongest part of its sector group.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 825.5 GBP | 14.3% | 788.4 GBP | 637.1 GBP | -0.91 | 10.20 | 96.3K | Off |
| 5 Jun 2026 | 722.0 GBP | 3.4% | 790.0 GBP | 635.0 GBP | -1.05 | -1.09 | 94.4K | Off |
| 29 May 2026 | 698.0 GBP | 1.2% | 799.6 GBP | 633.6 GBP | -1.10 | -3.45 | 81.9K | Off |
| 22 May 2026 | 690.0 GBP | 1.5% | 805.1 GBP | 633.3 GBP | -0.94 | -3.83 | 49.9K | Off |
| 15 May 2026 | 679.5 GBP | -1.5% | 811.1 GBP | 634.2 GBP | -0.77 | -1.51 | 123.0K | Off |
| 8 May 2026 | 689.5 GBP | 1.9% | 820.7 GBP | 635.2 GBP | -0.51 | 0.89 | 88.9K | Off |
| 1 May 2026 | 676.5 GBP | -16.1% | 835.7 GBP | 636.5 GBP | -0.16 | -0.94 | 288.3K | Off |
| 24 Apr 2026 | 806.0 GBP | -10.4% | 849.2 GBP | 637.4 GBP | -0.03 | 19.38 | 105.1K | On |
| 17 Apr 2026 | 900.0 GBP | -6.2% | 859.0 GBP | 637.5 GBP | 0.16 | 31.87 | 105.3K | On |
| 10 Apr 2026 | 960.0 GBP | 1.1% | 878.3 GBP | 636.8 GBP | 0.27 | 44.31 | 139.2K | Off |
| 3 Apr 2026 | 950.0 GBP | -2.9% | 880.0 GBP | 635.8 GBP | 0.37 | 48.20 | 62.4K | Off |
| 27 Mar 2026 | 978.5 GBP | 6.8% | 873.6 GBP | 635.1 GBP | 0.46 | 63.32 | 74.6K | Off |
| 20 Mar 2026 | 916.0 GBP | -20.0% | 858.6 GBP | 634.0 GBP | 0.53 | 57.46 | 123.6K | Off |
| 13 Mar 2026 | 1,145 GBP | 9.0% | 833.8 GBP | 633.4 GBP | 0.52 | 94.82 | 90.6K | On |